نتایج جستجو برای: antileukemic activity

تعداد نتایج: 1134946  

Journal: :Blood 2006
Yun Ge Idalia Montano Gabriella Rustici Wendy J Freebern Cynthia M Haggerty Wenwu Cui Damaris Ponciano-Jackson G V R Chandramouli Erin R Gardner William D Figg Mones Abu-Asab Maria Tsokos Sharon H Jackson Kevin Gardner

Using a novel cell-based assay to profile transcriptional pathway targeting, we have identified a new functional class of thalidomide analogs with distinct and selective antileukemic activity. These agents activate nuclear factor of activated T cells (NFAT) transcriptional pathways while simultaneously repressing nuclear factor-kappaB (NF-kappaB) via a rapid intracellular amplification of react...

2014
Elspeth M. Beauchamp Ewa M. Kosciuczuk Ruth Serrano Dhaval Nanavati Elden P. Swindell Benoit Viollet Thomas V. O'Halloran Jessica K. Altman Leonidas C. Platanias

Arsenic trioxide (As2O3) exhibits potent antineoplastic effects and is used extensively in clinical oncology for the treatment of a subset of patients with acute myeloid leukemia (AML). Although As2O3 is known to regulate activation of several signaling cascades, the key events, accounting for its antileukemic properties, remain to be defined. We provide evidence that arsenic can directly bind ...

2006
Guido J. Tricot Hiremagalur N. Jayaram Elizabeth Lapis Yutaka Natsumeda Craig R. Nichols Pat Kneebone Nyla Heerema George Weber Ronald Hoffman

Tiazofurin (2-/3-i>-ribofuranosylthiazole-4-carboxamide, NSC 286193), a selective inhibitor of the activity of IMP dehydrogenase (EC 1.1.1.205), the rate-limiting enzyme of de novo GTP biosynthesis, provided in end stage leukemic patients a rapid decrease of IMP dehydrogenase activity and GTP concentration in the blast cells and a subsequent decline in blast cell count. Sixteen consecutive pati...

Journal: :The Journal of Experimental Medicine 1973
Robert L. Kassel Lloyd J. Old Elizabeth A. Carswell Nancy C. Fiore William D. Hardy

AKR mice with spontaneous leukemia were infused with normal serum from a variety of species. Leukemia cell destruction was produced by serum from strains of mice possessing the full spectrum of complement components, but not by serum from strains with a genetically determined deficiency of C5. Serum from guinea pigs, horses, and humans also causes destruction of leukemia cells. The antileukemic...

Journal: :Journal of Translational Medicine 2021

Abstract Background Fatty acid oxidation (FAO) provides an important source of energy to promote the growth leukemia cells. Carnitine palmitoyltransferase 1a(CPT1a), a rate-limiting enzyme essential step FAO, can facilitate cancer metabolic adaptation. Previous reports demonstrated that CPT1a acts as potential molecular target in solid tumors and hematologic disease. However, no systematic stud...

2006
Philip Bedford Gerhard Eisenbrand

DNA is considered to be an important target for the antitumor and toxic properties of the Chloroethylnitrosoureas. Since the main target for their dose-limiting toxicity and the antileukemic efficacy is believed to be the bone marrow, we have compared the formation and subsequent removal of DNA-DNA interstrand cross-links in the bone marrow of rats which had received a single i.p. injection (10...

Journal: :Nagoya journal of medical science 1971
H Nagase

A study was made on serum and urinary muramidase in 56 patients with leukemia and other hematologic disorders. Serum and urinary muramidase levels prior to antileukemic therapy were elevated in monocytic leukemia, while not so increased in paramyeloblastic leukemia. In all patients with acute lymphocytic leukemia pretreatment serum enzyme activities were decreased below normal, whereas those in...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید